Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Pregnancy With Insomnia: a Trial of Acupuncture (GAS)

27. juni 2017 oppdatert av: Assistance Publique - Hôpitaux de Paris

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.

GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.

Studieoversikt

Status

Ukjent

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Scientific justification:

- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.

Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.

  • To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
  • Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.

Population:

The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.

Objectives:

  • Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
  • Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .

Study design:

  • Study Type: Multicentre, Interventional, randomized, 2 parallel groups
  • Endpoint Classification: Efficacy Study
  • Intervention Model: Parallel Assignment
  • Masking: Single blind (patient blinded to intervention)
  • Primary Purpose: Treatment
  • One acupuncture session weekly for 4 consecutive weeks

Visits:

  • Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
  • Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
  • Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
  • End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.

Studietype

Intervensjonell

Registrering (Forventet)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • Age > 18 years
  • Singleton pregnancy
  • Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
  • Insomnia Severity Index ≥ 10
  • Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
  • Patient understanding the study
  • Informed consent signed
  • Social insurance available at inclusion and until the end of pregnancy

Exclusion Criteria:

  • Threatened premature labor
  • Small fetus for gestational age
  • Pre-eclampsia
  • Insomnia starting before pregnancy
  • Use of psychotropic drugs before pregnancy
  • Use of recreational drugs during pregnancy
  • Known psychiatric disorder
  • Anticoagulant therapy
  • Patient reporting insomnia results from chronic or acute pain
  • Obstructive sleep apnea (OSA) requiring treatment
  • Patient under antidepressant therapy
  • Patient under legal guardianship or deprived of freedom

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Sham-komparator: Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Insomnia severity index (ISI)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pittsburgh Sleep Quality Index (PSQI)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Hospital Anxiety and Depression Scale (HADS)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of each psychotropic medicine
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of any drug.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of alcohol
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of alcohol.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of tobacco
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of tobacco.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of cannabis
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of cannabis.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of other recreational substances or medicine
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Inclusion visit and 5 weeks after the first acupuncture session
Difference in the frequency of restless leg syndrome
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session

According to the guidelines of the International Restless Legs Syndrome Study Group.

The diagnosis of restless leg will rely on the presence of all of the following criteria:

  1. Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
  2. Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
  3. Symptoms are worse at rest with at least temporary relief by activity.
  4. Symptoms are worse later in the day or at night.
Inclusion visit and 5 weeks after the first acupuncture session
Perinatal outcome - Gestational age at birth
Tidsramme: At birth
The gestational age at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth weight
Tidsramme: At birth
The weight (in gr) at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth height
Tidsramme: At birth
The height (in cm) at birth of the newborn will be recorded.
At birth
Perinatal outcome - sex
Tidsramme: At birth
The sex of the newborn will be recorded.
At birth
Perinatal outcome - perinatal mortality
Tidsramme: At birth
The perinatal mortality will be recorded.
At birth
Perinatal outcome - five minutes Apgar score
Tidsramme: At birth
The five minutes Apgar score will be recorded.
At birth
Perinatal outcome - cesarean section rate
Tidsramme: At birth.
Cesarean section rate will be recorded.
At birth.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Stéphanie Nicolian, Midewife, Assistance Publique - Hôpitaux de Paris

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Forventet)

1. september 2017

Primær fullføring (Forventet)

1. januar 2019

Studiet fullført (Forventet)

1. mai 2019

Datoer for studieregistrering

Først innsendt

23. mai 2017

Først innsendt som oppfylte QC-kriteriene

19. juni 2017

Først lagt ut (Faktiske)

21. juni 2017

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

28. juni 2017

Siste oppdatering sendt inn som oppfylte QC-kriteriene

27. juni 2017

Sist bekreftet

1. april 2017

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

Nei

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Søvnløshet

3
Abonnere